Shishir Sinha
Directeur des opérations chez Qualigen, Inc.
Profil
Shishir K.
Sinha is currently the COO, Secretary & Vice President at Qualigen, Inc. He previously worked as a Manufacturing Director at Ngen, Inc. from 2005 to 2006, at Sequenom, Inc. from 2001 to 2004, and at Celera Diagnostics LLC from 2004 to 2006.
He also served as a Packaging Manager at Sandoz Pharmaceuticals Corp.
from 2000 to 2001.
Additionally, Mr. Sinha is currently the Chief Operating Officer, Secretary & VP at Qualigen Therapeutics, Inc. from 2006 to 2023.
He holds a graduate degree from The Johns Hopkins University and an undergraduate degree from the University of California, Berkeley.
Postes actifs de Shishir Sinha
| Sociétés | Poste | Début |
|---|---|---|
Qualigen, Inc.
 Qualigen, Inc. Medical SpecialtiesHealth Technology Qualigen, Inc. operates as a biotechnology company that develops and commercializes novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a diagnostic platform. The company was founded by Michael S. Poirier in 1996 and is headquartered in Carlsbad, CA. | Directeur des opérations | - |
Anciens postes connus de Shishir Sinha
| Sociétés | Poste | Fin |
|---|---|---|
| QUALIGEN THERAPEUTICS, INC. | Directeur des opérations | 16/02/2023 |
Celera Diagnostics LLC
 Celera Diagnostics LLC Medical/Nursing ServicesHealth Services Celera Diagnostics LLC discovers, develops and commercializes molecular diagnostics. The firm enables physicians to diagnose, monitor and treat disease. It manufactures products for infectious disease testing and for genetic conditions such as cystic fibrosis. The company was founded in 2001 by Kathy Ordoñez and is headquartered in Alameda, CA. | Corporate Officer/Principal | 01/01/2006 |
| NGEN INC | Corporate Officer/Principal | 01/01/2006 |
| SEQUENOM, INC. | Corporate Officer/Principal | 01/01/2004 |
| Sandoz Pharmaceuticals Corp. | Corporate Officer/Principal | 01/01/2001 |
Formation de Shishir Sinha
| The Johns Hopkins University | Graduate Degree |
| University of California, Berkeley | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| QUALIGEN THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
Qualigen, Inc.
Qualigen, Inc. Medical SpecialtiesHealth Technology Qualigen, Inc. operates as a biotechnology company that develops and commercializes novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a diagnostic platform. The company was founded by Michael S. Poirier in 1996 and is headquartered in Carlsbad, CA. | Health Technology |
Sequenom, Inc.
 Sequenom, Inc. Medical SpecialtiesHealth Technology Sequenom, Inc. engages in the provision of early patient management information. It develops and commercializes molecular diagnostic testing services that serve women's health and oncology markets. The company was founded by Hubert Koester and Charles R. Cantor in October 09, 1996 and is headquartered in Burlington, NC. | Health Technology |
Celera Diagnostics LLC
Celera Diagnostics LLC Medical/Nursing ServicesHealth Services Celera Diagnostics LLC discovers, develops and commercializes molecular diagnostics. The firm enables physicians to diagnose, monitor and treat disease. It manufactures products for infectious disease testing and for genetic conditions such as cystic fibrosis. The company was founded in 2001 by Kathy Ordoñez and is headquartered in Alameda, CA. | Health Services |
Ngen, Inc.
 Ngen, Inc. Medical SpecialtiesHealth Technology Ngen, Inc. advanced diagnostics provides physicians and patients worldwide with sophisticated information to predict, diagnose and treat disease. Research and clinical reference labs use the highly accurate and reliable NanoChip(R) Molecular Biology Workstation, NanoChip(R) Electronic Microarray and broad suite of analyte specific reagents to develop diagnostic tests for variety of diseases. Nanogen also offers a broad portfolio of patented nucleic acids chemistries and molecular tools that accelerate genomic analysis and are compatible with many systems. The SynX subsidiary offers a line of point-of-care diagnostic tests and is building expertise in cardiac related health conditions. Nanogen's ten years of pioneering research involving nanotechnology may also have future applications in medical diagnostics, biowarfare and other industries. The company is headquartered in San Diego, CA | Health Technology |
| Sandoz Pharmaceuticals Corp. |